TNFSF13B and interstitial lung disease: These findings indicate that BAFF levels may reflect ILD fibrotic severity and be a moderately useful biomarker for distinguishing F-ILD from NF-ILD, also suggesting that BAFF might be a new potential target for therapy in patients with CTD-ILD as well.